We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Telephone Enhancement Procedure for Continuing Care - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00067171
First Posted: August 13, 2003
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Institute on Drug Abuse (NIDA)
August 12, 2003
August 13, 2003
January 12, 2017
January 2003
January 2004   (Final data collection date for primary outcome measure)
Treatment compliance, drug and alcohol astinence
Not Provided
Complete list of historical versions of study NCT00067171 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
The purpose of this study is to test a feasibility study of a telephone enhancement procedure (TELE) to improve participation in continuing care activities.
Not Provided
Interventional
Phase 3
Allocation: Randomized
Substance-Related Disorders
Behavioral: Behavior Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
339
January 2004
January 2004   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Residential substance abuse treatment patients who reside within the pre-specified catchment area who complete continuing care plans prior to discharge.
  • Voluntary admit to residential treatment center; substance abuse or dependence; reside in targeted counties; and may be reached by telephone.
Sexes Eligible for Study: All
18 Years to 99 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00067171
NIDA-CTN-0011-1
Yes
Not Provided
Not Provided
Robert Hubbard, Ph.D., Duke University
Duke University
Not Provided
Principal Investigator: Robert Hubbard, Ph.D. Duke University
National Institute on Drug Abuse (NIDA)
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP